NNMT and prostate carcinoma: Murine prostate cancer cells with mesenchymal/stemness phenotypes (DVL3-SCM), that exhibit NNMT overexpression and high aggressiveness <i>in vivo</i>, also show increased sensitivity to FK866 compared with their parental counterparts (DVL3-PAR).